TNF
Showing 26 - 50 of 6,796
Glioblastoma Trial in Zürich (Onfekafusp alfa, Temozolomide)
Recruiting
- Glioblastoma
- Onfekafusp alfa
- Temozolomide
-
Zürich, SwitzerlandUniversitatSpital USZ
Apr 7, 2022
GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis
Completed
- Periodontitis
- Periodontal clinical measurements and GCF sampling
-
Aydın, TurkeyAdnan Menderes University, Faculty of Dentistry, Department of P
Dec 8, 2022
IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid
Not yet recruiting
- Apical Periodontitis
- The teeth diagnosed with chronic apical periodontitis
- (no location specified)
Feb 1, 2022
Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)
Active, not recruiting
- Soft Tissue Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center (SORC) Cancer Center of Souther
Apr 19, 2022
Spondyloarthritis, Crohn Disease, Ulcerative Colitis Trial in Pessac (blood sample, stool samples, food questionnaire)
Completed
- Spondyloarthritis
- +2 more
- blood sample
- +4 more
-
Pessac, FranceCHU de Bordeaux - service d'Hépato-gastroentérologie
May 25, 2022
BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)
Not yet recruiting
- BCC - Basal Cell Carcinoma
- +6 more
-
Marseille, FranceHôpital de la Timone
Jun 22, 2022
Crohn Disease Trial in Paris (Fecal Microbiota Transplantation (FMT), Sham-transplantation ())
Recruiting
- Crohn Disease
- Fecal Microbiota Transplantation (FMT)
- Sham-transplantation (placebo)
-
Paris, FranceGastroenterology Department of Saint Antoine Hospital
Jun 20, 2022
Rates of Dementia and Alzheimer's Disease in Participants
Completed
- Dementia
- Alzheimer Disease
-
Titusville, New JerseyJanssen R&D
Oct 15, 2021
Uveitis, Adalimumab Trial in Guangzhou (reduction or discontinuation of Adalimumab)
Recruiting
- Uveitis
- Adalimumab
- reduction or discontinuation of Adalimumab
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Dec 9, 2021
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
Periodontal Diseases Trial in Konya (ELISA)
Completed
- Periodontal Diseases
- ELISA
-
Konya, TurkeyNecmettin Erbakan University
May 7, 2023
Melanoma Trial in Lille, Montpellier, Toulouse (Tumor biopsy specimens and blood samples)
Completed
- Melanoma
- Tumor biopsy specimens and blood samples
-
Lille, France
- +2 more
Nov 23, 2021
Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)
Recruiting
- Axial Spondyloarthritis
- Blood sample
- +2 more
-
Besançon, FranceCentre Hospitalier Universitaire de Besançon
May 31, 2022
Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric
Completed
- Acute Graft-versus-host Disease
-
Trieste, ItalyIRCCS Burlo Garofolo
Apr 11, 2023
Biologics or Small Molecule Therapies in Inflammatory Bowel
Completed
- Crohn's Disease
- Ulcerative Colitis
-
New York, New York
- +1 more
Jan 9, 2023
IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- Adalimumab
-
Gent, Belgium
- +6 more
May 17, 2022
Rheumatoid Arthritis Trial in Matsumoto (Drug: "Salirumab", Drug: "Tocilizmab", Drug: "Abatacept")
Recruiting
- Rheumatoid Arthritis
- Drug: "Salirumab"
- +2 more
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Nerve Conduction Studies in Ankylosing Spondylitis
Completed
- Anti - TNF Therapy
- +2 more
- Anti-TNF agents
- Conventional therapy users for the last 5 years
-
Istanbul, TurkeyIstanbul Physical Medicine and Rehabilitation Training and resea
Jun 21, 2021